Ouverture officielle du siège, de l’installation de recherche et développement et de l’usine de fabrication de Scivita Medical

SUZHOU, Chine, 5 juin 2023 /PRNewswire/ — Le 2 juin 2023 (heure de Pékin), le siège de Scivita Medical, comprenant une installation de recherche et développement et une usine de fabrication a été officiellement ouvert dans le parc industriel de Suzhou (SIP). Cette occasion mémorable marque une étape importante pour Scivita Medical, qui consolide ses … Read more

Late-breaking SCG101 Data Show 100% HBsAg+ Hepatocyte Eradication and 74.5% HCC Tumour Reduction With Single Dose HBsAg-specific TCR-T Cell Therapy

SINGAPORE, June 4, 2023 /PRNewswire/ — SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, presented late-breaking data from its first-in-class autologous HBsAg-specific T-Cell receptor-engineered T Cell (TCR-T) Therapy – SCG101 – at the International Society for Cell & Gene Therapy (ISCT) conference in Paris, France. … Read more

Harbour BioMed Announces First Patient Dosed in Phase I Study of First-in-Class Anti-B7H7 (HHLA2) Antibody HBM1020

HBM1020 is a first-in-class therapeutic monoclonal antibody against B7H7/HHLA2 entering clinical development globally. HBM1020 was generated from Harbour Mice® H2L2 transgenic mice platform. HBM1020 has great potential to address huge unmet medical needs in patients with advanced malignancies. CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, June 4, 2023 /PRNewswire/ — Harbour BioMed (HKEX: 02142) announced … Read more

LOTTE BIOLOGICS to Kick off their CDMO Business Campaign at ‘BIO International Convention 2023’

Exclusive booth and private meeting rooms to be utilized for robust business initiatives SEOUL, South Korea, June 4, 2023 /PRNewswire/ — LOTTE BIOLOGICS, under the leadership of CEO Richard Lee, enthusiastically disclosed its participation in the upcoming ‘BIO International Convention 2023’ to be held from June 5th to June 8th, 2023, at the illustrious Boston … Read more

VVN539 met primary study endpoints in US phase IIa clinical study for the treatment of glaucoma

SHANGHAI, June 4, 2023 /PRNewswire/ — This was a Phase 2, double-masked, randomized, vehicle-controlled, dose-response study to assess the safety and ocular hypotensive efficacy of VVN539 in subjects with primary open angle glaucoma (POAG) or ocular hypertension (OHT). The primary objective was to evaluate the ocular hypotensive efficacy of 2 concentrations of VVN539 Ophthalmic Solution (0.04% … Read more

Innovent Presents Phase 1b Clinical Data of IBI110 (Anti-LAG-3 Monoclonal Antibody) at the 2023 ASCO Annual Meeting

ROCKVILLE, Md. and SUZHOU, China, June 4, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major diseases, announced that Phase 1b clinical data of IBI110 (anti-LAG-3 monoclonal antibody) in the first-line treatment of … Read more

Vial to Sponsor and Present at Clinical Trials at the Summit (CTS) 2023 in Park City, UT

SAN FRANCISCO, June 4, 2023 /PRNewswire/ — Vial, a global tech-first CRO providing next-generation clinical trial management services, announced it will be sponsoring and presenting at the 2023 Clinical Trials at the Summit (CTS) in Park City, UT, Saturday, June 10. CTS 2023 will be taking place at the Pendry Park City. The event unites … Read more

DDS Marketing is the First Dental Marketing Company Using AI

LOS ANGELES, May 30, 2023 /PRNewswire/ — DDS Marketing, a cutting-edge dental marketing company founded by Amir Moghaddam and Ardi Safi, has made headlines for their innovative use of AI technology in optimizing dental marketing campaigns. By utilizing AI-powered algorithms, DDS Marketing has revolutionized the way dental practices advertise on platforms such as Google Ads … Read more

Seniors conquered by the future residence of Clos du Ségala by Valérie Bernadou

the essential The public meeting on Saturday attracted a large number of seniors who came to inquire about the future residence at Lagarrigue. Visits to a model apartment from June 12. Summer 2018, return from vacation and a lot of concern for the Bernadou family.In her apartment in Lameilhé, Valérie’s mother-in-law falls down the stairs. … Read more

SOUTH JERSEY BEHAVIORAL HEALTH RESOURCES PROVIDES NOTICE OF DATA PRIVACY EVENT

PENNSAUKEN, N.J., June 4, 2023 /PRNewswire/ — On April 5, 2023, South Jersey Behavioral Health Resources (“SJBHR”) discovered encrypted files on certain computer systems.  SJBHR immediately launched an investigation, with the assistance of third-party forensic specialists, to determine the nature and scope of the activity.  The investigation determined that there was unauthorized access to certain of its … Read more